Farther Finance Advisors’s Akero Therapeutics AKRO Stock Holding History

Farther Finance Advisors’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-31	Closed	-$1.47K	–	5455
2025 Q3	$1.47K	Buy	31 +20	+182%	+$968	﹤0.01%	4246
2025 Q2	$587	Buy	+11	New	+$500	﹤0.01%	4015
2025 Q1	–	Sell	-1	Closed	-$28	–	4269
2024 Q4	$28	Hold	1	–	–	﹤0.01%	3915
2024 Q3	$29	Hold	1	–	–	﹤0.01%	3906
2024 Q2	$23	Hold	1	–	–	﹤0.01%	3750
2024 Q1	$24	Hold	1	–	–	﹤0.01%	3517
2023 Q4	$23	Buy	+1	New	+$20	﹤0.01%	3448

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Farther Finance Advisors's AKRO Position: Q4 2025 in Review

Farther Finance Advisors sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 31 shares — an estimated $1.47K sold.

Farther Finance Advisors first reported a position in AKRO in Q4 2023 and held it in 7 quarters. The position peaked at $1.47K in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Farther Finance Advisors reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Farther Finance Advisors sold 31 Akero Therapeutics shares in Q4 2025, an estimated $1.47K.
Farther Finance Advisors first reported a position in Akero Therapeutics in Q4 2023 and held it in 7 quarters.
Farther Finance Advisors's Akero Therapeutics position peaked at $1.47K in Q3 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Farther Finance Advisors's 13F filing for Q4 2025, filed 23 Jan 2026.